Alembic Pharmaceuticals Ltd. - Research Center
533573 APLLTD Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | |
|---|---|---|---|---|---|
| Sales | 1,160.33 | 1,304.32 | 1,232.83 | 1,189.77 | 1,269.69 |
| Operating profit | 126.63 | 291.30 | 282.75 | 236.95 | 276.97 |
| Interest | 8.70 | 5.92 | 4.31 | 4.41 | 2.03 |
| Gross profit | 118.55 | 296.98 | 279.85 | 234.25 | 276.68 |
| EPS (Rs) | 3.69 | 12.79 | 9.85 | 7.95 | 9.80 |
Quarterly
results in details
| Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | |
|---|---|---|---|---|---|
| Other income | 0.62 | 11.59 | 1.42 | 1.71 | 1.74 |
| Stock adjustment | 31.04 | -22.19 | 29.23 | 28.96 | -17.58 |
| Raw material | 258.66 | 304.05 | 273.64 | 247.05 | 287.02 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 259.07 | 246.58 | 253.22 | 266.80 | 261.59 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 484.94 | 484.58 | 393.99 | 410.02 | 461.69 |
| Provisions made | - | - | - | - | - |
| Depreciation | 46.09 | 45.95 | 45.34 | 44.53 | 43.49 |
| Taxation | - | -0.34 | 40.94 | 33.36 | 40.50 |
| Net profit / loss | 72.46 | 251.37 | 193.58 | 156.36 | 192.69 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 10.91 | 22.33 | 22.93 | 19.92 | 21.81 |
| GPM (%) | 10.21 | 22.57 | 22.67 | 19.66 | 21.76 |
| NPM (%) | 6.24 | 19.10 | 15.68 | 13.12 | 15.16 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis